Cargando…
CSF Concentrations of cAMP and cGMP Are Lower in Patients with Creutzfeldt-Jakob Disease but Not Parkinson's Disease and Amyotrophic Lateral Sclerosis
BACKGROUND: The cyclic nucleotides cyclic adenosine-3′,5′-monophosphate (cAMP) and cyclic guanosine-3′,5′-monophosphate (cGMP) are important second messengers and are potential biomarkers for Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and Creutzfeldt-Jakob disease (CJD). METH...
Autores principales: | Oeckl, Patrick, Steinacker, Petra, Lehnert, Stefan, Jesse, Sarah, Kretzschmar, Hans A., Ludolph, Albert C., Otto, Markus, Ferger, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292568/ https://www.ncbi.nlm.nih.gov/pubmed/22396786 http://dx.doi.org/10.1371/journal.pone.0032664 |
Ejemplares similares
-
Identification of novel target proteins of cGMP/cAMP signaling pathway using cGMP/cAMP capture compound mass spectrometry (CCMS)
por: Luo, Yan, et al.
Publicado: (2009) -
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
por: Steinacker, Petra, et al.
Publicado: (2016) -
Differential regulation of Paramecium ciliary motility by cAMP and cGMP
Publicado: (1988) -
Biophysical Techniques for Detection of cAMP and cGMP in Living Cells
por: Sprenger, Julia U., et al.
Publicado: (2013) -
IL-4 induces cAMP and cGMP in human monocytic cells
por: Dugas, B., et al.
Publicado: (1995)